Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11613555 | PMC |
| http://dx.doi.org/10.1016/j.gimo.2023.100827 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Bicaval TricValve Implantation in Patients With Severe Tricuspid Regurgitation: 1-Year Outcomes From the TricBicaval Registry.
JACC Cardiovasc Interv
August 2025
Hospital Universitario Ramon y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain; Centro de Investigación Biomédica En Red - Enfermedades Cardiovasculares, Instituto de Salud Carlos III, Madrid, Spain.
Background: Caval valve implantation is currently the only alternative for patients with severe tricuspid regurgitation (TR) who are deemed unsuitable candidates for transcatheter orthotopic therapies.
Objectives: The aim of this study was to assess the efficacy and safety of TricValve system at 1-year follow-up.
Methods: TricBicaval registry is a multicenter registry that retrospectively enrolled all consecutive patients with severe TR treated with TricValve system.
Double versus single blastocyst biopsy and vitrification in preimplantation genetic testing (PGT) cycles: protocol for a systematic review and meta-analysis of clinical and neonatal outcomes.
Syst Rev
April 2025
Kofinas Fertility Group 65, Broadway, New York, NY, 10006, USA.
Background: The number of re-biopsied blastocysts is widely increasing in IVF cycles and concerns regarding retesting, which involves double biopsy and vitrification-warming, have been raised. The re-biopsy intervention seems to significantly reduce the pregnancy potential of a blastocyst but the evidence is still restricted to retrospective observational studies reporting a low number of cycles with re-biopsied embryos. Additionally, the neonatal outcomes after the transfer of re-biopsied and re-vitrified embryos are poorly documented to date.
View Article and Find Full Text PDFA computational DNA methylation method to remove contaminated DNA from spent embryo culture medium for noninvasive preimplantation genetic testing.
EBioMedicine
April 2025
Biomedical Pioneering Innovation Center, State Key Laboratory of Female Fertility Promotion, Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Third Hospital, School of Life Sciences, Peking University, Beijing, China; Beijing Advanced Innovation Center for Genomics, Third H
Background: In the last fifty years, assisted reproductive technology (ART) has achieved remarkable breakthroughs, culminating in the birth of 12 million infants. At the heart of ART success is preimplantation genetic testing (PGT), which enables the detection of chromosomal anomalies, single-gene disorders, and structural rearrangements, enhancing embryo selection and mitigating genetic risk. However, current PGT methods, including trophectoderm (TE) biopsy, face limitations such as challenges related to convenience and potential impacts on embryonic health.
View Article and Find Full Text PDFLack of Bridge to Recovery in Pediatric Dilated Cardiomyopathy With Left Ventricular Noncompaction.
Ann Thorac Surg Short Rep
March 2025
Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Yamadaoka, Osaka, Japan.
Background: This study assessed the possibility of a bridge to recovery using the Berlin Heart EXCOR and the histologic characteristics of pediatric patients with dilated cardiomyopathy accompanied by a left ventricular noncompaction phenotype.
Methods: Of the 17 pediatric patients with dilated cardiomyopathy who underwent Berlin Heart EXCOR implantation between 2013 and 2020, 6 were diagnosed with left ventricular noncompaction association. The patients were classified into 2 groups: the dilated cardiomyopathy group and dilated cardiomyopathy with the left ventricular noncompaction phenotype group.